| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |